Cardiology
Latest news
1101 articles · 20 / page
The BMPR2 Nexus: How Breast Cancer Acts as a Second Hit for Pulmonary Hypertension
Emerging evidence identifies a bidirectional link between breast cancer and pulmonary arterial hypertension (PAH) driven by BMPR2 signaling and IL-1β-mediated inflammation. This study suggests breast cancer may serve as a critical second hi
Integrating Serum Metabolomics and Polygenic Risk Scores Redefines 5-Year Atrial Fibrillation Prediction
A massive UK Biobank study demonstrates that combining serum metabolomics with polygenic risk scores and clinical data significantly improves the prediction of incident atrial fibrillation, identifying key metabolic markers like linoleic ac
AKI and Diuretic Resistance: Identifying the High-Risk Phenotype in SCAI Stage B Cardiogenic Shock
New research highlights that nearly a quarter of SCAI Stage B cardiogenic shock patients deteriorate. Acute kidney injury and diuretic resistance serve as critical early warning signs, providing clinicians a window for proactive interventio
Targeted HEV Modulation: A Novel Antibody-Drug Conjugate Strategy to Overcome Cardiac Allograft Rejection
Researchers have developed a first-in-class antibody-drug conjugate targeting High Endothelial Venules via the CHST4 enzyme. This therapy promotes regulatory T cell induction and long-term heart transplant survival in murine models using si
Angiographic Burden of Coronary Atherosclerosis: The Critical Mediator Between ASCVD Risk Factors and Cardiovascular Outcomes
This Mendelian randomization study reveals that coronary plaque burden significantly mediates the link between traditional risk factors and adverse events like myocardial infarction and heart failure, reinforcing the necessity of early prim
Percutaneous Coronary Intervention Before TAVR: A Nationwide Synthesis of Clinical Outcomes and Bleeding Risks
A nationwide Swedish registry analysis demonstrates that routine PCI before TAVR for significant coronary artery disease does not improve survival or reduce urgent revascularization, but significantly increases bleeding risk while reducing
Sex-Specific Risk Thresholds in Coronary Artery Disease: Why Plaque Burden Metrics Demand Re-evaluation in Women
A secondary analysis of the PROMISE trial reveals that women face elevated cardiovascular risk at significantly lower coronary plaque thresholds than men, necessitating a paradigm shift toward sex-stratified interpretation of coronary CT an
Restrictive Physiology, Not Systolic Failure, Defines the Clinical Landscape of Cardiac Amyloidosis
A large-scale study identifies restrictive physiology as the dominant phenotype in cardiac amyloidosis. While preserved function offers better survival, rapid progression to restriction underscores the importance of early diagnosis and moni
NOACs Superior to Warfarin for Systemic Embolic Events: Lessons from a 71,683-Patient Meta-Analysis
A large-scale individual patient data meta-analysis reveals that while systemic embolic events are less common than strokes in atrial fibrillation, they carry an equivalent mortality risk. NOACs significantly reduce this risk by 29% compare
The Rising Tide of Cardiovascular Disease: AHA’s 2050 Forecast for Women’s Heart Health
A major AHA scientific statement forecasts a significant increase in cardiovascular disease and risk factors among U.S. women by 2050. It highlights rising rates of obesity and hypertension while emphasizing the urgent need for targeted int
Nurse-Led Integrated Care Slashes Recurrence and Boosts Quality of Life After Atrial Fibrillation Ablation
The NURSECAT-AF trial demonstrates that structured nurse-led care significantly improves quality of life and reduces arrhythmia recurrence and emergency visits by 80% in patients undergoing their first catheter ablation for atrial fibrillat
VOYAGER-PAD Insight: Prior Revascularization History Mandates More Aggressive Antithrombotic Therapy
A VOYAGER-PAD sub-analysis reveals that patients with prior limb revascularization are at significantly higher risk for adverse events but derive a greater relative benefit from low-dose rivaroxaban plus aspirin.
The QTc Paradox: Why Prolonged QT Intervals May Predict Lower Recurrent Stroke Risk in Atrial Cardiopathy
A secondary analysis of the ARCADIA trial reveals a surprising inverse relationship: prolonged QTc intervals were associated with a significantly reduced risk of recurrent stroke in patients with atrial cardiopathy, challenging existing par
Low-Dose Rivaroxaban Fails to Significantly Reduce Left Ventricular Thrombosis in Anterior STEMI: Results of the APERITIF Trial
The APERITIF randomized clinical trial found that adding low-dose rivaroxaban to dual antiplatelet therapy (DAPT) did not significantly reduce the incidence of left ventricular thrombus at one month in anterior STEMI patients, while signifi
Global Variations in Patient Radiation Exposure for Coronary Artery Disease Diagnosis: A Synthesized Review of the INCAPS 4 Findings
This review analyzes global radiation doses in CAD diagnostic imaging based on the INCAPS 4 study. It highlights significant disparities across modalities and regions, revealing that patients in low-income countries and those undergoing CCT
Long-Term Clinical Outcomes After Patent Foramen Ovale (PFO) Closure: A 20-Year Follow-Up Study
This article examines the 20-year safety and efficacy of transcatheter PFO closure in patients with paradoxical embolism, highlighting low recurrence rates but significant long-term bleeding risks associated with antithrombotic therapy.
AI-Enabled Stethoscopes in Primary Care: Why Implementation Science Matters More Than Algorithm Accuracy
The TRICORDER trial demonstrates that while AI stethoscopes are capable of detecting heart failure, atrial fibrillation, and valvular disease, their real-world implementation in UK primary care did not yield a statistically significant incr
Twice-Yearly Inclisiran Successfully Lowers LDL-C in Adolescents with Heterozygous Familial Hypercholesterolaemia: Insights from ORION-16
The ORION-16 trial demonstrates that inclisiran, a twice-yearly siRNA therapy, significantly and safely reduces LDL cholesterol in adolescents with HeFH, offering a potent new tool for early cardiovascular risk management in high-risk pedia
Beyond Information Delivery: Why Survivorship Care Plans Alone May Not Reduce Cardiovascular Risk in Cancer Survivors
This article examines the CHIIP study, a randomized clinical trial evaluating whether survivorship care plan-based counseling improves cardiovascular risk factor control in childhood cancer survivors. Findings suggest that while documentati
Healing the Heart with Tradition: The Promise of the MUTTON-HF Program in the Navajo Nation
A groundbreaking clinical trial demonstrates that medically tailored meals featuring traditional Indigenous foods can significantly improve heart failure outcomes and food security in rural Navajo communities.
Browse by specialty
Open language-specific specialty feeds and department pages.